Ebola

May 2017: The Antibody Update – Inhibition of Indolamine 2, 3 Dioxygenase (IDO) for Cancer Immunotherapy Researchers have found that a drug which inhibits IDO can increase the effectiveness of cancer immunotherapy. Epacadostat, which is an IDO inhibitor, successfully increased...

Share this post:

Merck’s Ebola Vaccine is 100% Effective December 2016: The Antibody Update – An extremely effective Ebola virus vaccine created by Merck was recently tested in Guinea with 100% effectiveness. Though the vaccine is late for the worst part of the...

Share this post:

Multiple Sclerosis Antibody May Be Linked to JC Virus Infection Multiple sclerosis patients taking Natalizumab showed an increase in the number of cases of the neurodegenerative John Cunningham virus (JCV). JCV can cause a fatal brain disease. Natalizumab is a...

Share this post: